Japan Approves Label Expansions for Rozlytrek, Alecensa and More

February 25, 2020
The Ministry of Health, Labor and Welfare (MHLW) approved additional indications for a batch of drugs on February 21 including two cancer medicines from Chugai Pharmaceutical - Rozlytrek (entrectinib) and Alecensa (alectinib). The MHLW gave the blessing to Rozlytrek, a...read more